SUPN Return on Tangible Equity | SUPERNUS PHARMACEUTICALS, INC.

SUPERNUS PHARMACEUTICALS, INC. (SUPN) Return on Tangible Equity

2026-06-30: Return Tang Equity -12.06%.
2026-03-31: Return Tang Equity -3.04%.
2025-12-31: Return Tang Equity -4.12%.
2025-09-30: Return Tang Equity -2.06%.

Complete source-backed return tang equity history.

Available history: 2010-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-12.06%
2026-03-31	-3.04%
2025-12-31	-4.12%
2025-09-30	-2.06%
2025-06-30	6.82%
2025-03-31	6.78%
2024-12-31	8.05%
2024-09-30	6.71%
2024-06-30	0.62%
2024-03-31	-1.91%
2023-12-31	0.16%
2023-09-30	3.23%
2023-06-30	5.40%
2023-03-31	6.55%
2022-12-31	7.90%
2022-09-30	5.13%
2022-06-30	7.93%
2022-03-31	10.30%
2021-12-31	7.66%
2021-09-30	11.17%
2021-06-30	14.17%
2021-03-31	16.44%
2020-12-31	19.05%
2020-09-30	20.89%
2020-06-30	20.47%
2020-03-31	18.97%
2019-12-31	19.01%
2019-09-30	19.01%
2019-06-30	20.10%
2019-03-31	21.49%
2018-12-31	24.54%
2018-09-30	23.45%
2018-06-30	22.24%
2018-03-31	20.88%
2017-12-31	21.47%
2017-09-30	23.09%
2017-06-30	45.39%
2017-03-31	47.08%
2016-12-31	47.75%
2016-09-30	48.51%
2016-06-30	18.42%
2016-03-31	13.81%
2015-12-31	15.68%
2015-09-30	-18.03%
2015-06-30	4.27%
2015-03-31	5.90%
2014-12-31	-27.31%
2014-09-30	-10.53%
2014-06-30	-180.14%
2014-03-31	-315.81%
2013-12-31	-281.66%
2013-09-30	-669.56%
2013-06-30	-202.74%
2013-03-31	-142.69%
2012-12-31	-86.42%
2012-09-30	185.68%
2012-06-30	130.28%
2012-03-31	20287.23%
2011-12-31	569.89%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-4.12%
2024-12-31	8.05%
2023-12-31	0.16%
2022-12-31	7.90%
2021-12-31	7.66%
2020-12-31	19.05%
2019-12-31	19.01%
2018-12-31	24.54%
2017-12-31	21.47%
2016-12-31	47.75%
2015-12-31	15.97%
2014-12-31	-27.32%
2013-12-31	-281.66%
2012-12-31	-80.40%
2011-12-31	569.89%
2010-12-31	86.78%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Immunome Inc. (IMNM)	United States	$2.538B	-9.45
Disc Medicine, Inc. (IRON)	United States	$2.553B	-11.40
Nurix Therapeutics, Inc. (NRIX)	United States	$2.457B	-5.39
SELLAS Life Sciences Group, Inc. (SLS)	United States	$2.420B	-91.87
uniQure N.V. (QURE)		$2.416B	-4.93
Vera Therapeutics, Inc. (VERA)	United States	$2.402B	-7.67
Harmony Biosciences Holdings, Inc. (HRMY)	United States	$2.399B	11.67
MBX Biosciences, Inc. (MBX)	United States	$2.664B	-25.36
Mineralys Therapeutics, Inc. (MLYS)	United States	$2.353B	-6.82
Viridian Therapeutics, Inc.\DE (VRDN)	United States	$2.342B	-5.38